Patent · US Active

Benzylamino substituted quinazolines and derivatives as SOS1 inhibitors

US12053473B2 · kind B2 · utility

0Cited by

3References

5Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Dirk Kessler · Wien, AT
Christiane Kofink · Perchtoldsdorf, AT
Matthew Russell Netherton · Danbury, US
Juergen Ramharter · Wien, AT
Tobias Wunberg · Mödling, AT

Key dates

Filing date	Oct 22, 2020
Grant date	Aug 6, 2024
Priority date	—
Expiry date	Jan 4, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention encompasses compounds of formula (I) wherein the groups R1 to R7 have the meanings given in the claims and specification, their use as inhibitors of SOS1, pharmaceutical compositions which contain compounds of this kind and their use as medicaments/medical uses, especially as agents for treatment and/or prevention of oncological diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.